Private Equity: Buyouts & Venture Capital Investment (International Firms)
Greater China Region Guide 2024 : China
Band 2
Contact number
+852 2514 7600Chambers Review
Simpson Thacher & Bartlett has a skilled transactional practice which is acknowledged for its strength in major private equity acquisitions and investments. The firm is particularly active on cross-border and regional deals in the TMT, fintech and pharmaceutical sectors. It is notable for its strong working relationship with leading private equity houses, and continues to increase its global client base. The team is well suited to advise on deals involving both the USA and Greater China, leveraging its highly regarded private equity teams throughout the USA. The firm is also active on deals that involve India, South Korea and Japan.
Work Highlights
- Simpson Thacher & Bartlett acted for KKR on its investment into WE PARK.
Notable Practitioners
Ian Ho is noted for his skilful handling of cross-border acquisitions and investments. He is routinely instructed by high-profile investors and listed corporates alike.
Wang Yang remains a popular choice of adviser for international and Chinese investors and private equity firms. His work includes advising on a variety of investments in the healthcare and TMT sectors, among others.
"He is very responsive, hands-on, and always does all the deal documents himself. We rely on him a lot when negotiating and reviewing transaction documents."
Ranked Lawyers at
Simpson Thacher & Bartlett LLP
China